← Evidence map

ArticleOncoimmunology

CD44v6 as innovative sarcoma target for CAR-redirected CIK cells.

V Leuci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

31 papers cite it

2019
2020
2021
2022
2023
2024
2025
2026
cites it
Full record →Abstract, authors, funding and every citing paper · PMID 29721373